Literature DB >> 27919236

The psoriasis-associated deletion of late cornified envelope genes LCE3B and LCE3C has been maintained under balancing selection since Human Denisovan divergence.

Petar Pajic1, Yen-Lung Lin1, Duo Xu1, Omer Gokcumen2.   

Abstract

BACKGROUND: A common, 32kb deletion of LCE3B and LCE3C genes is strongly associated with psoriasis. We recently found that this deletion is ancient, predating Human-Denisovan divergence. However, it was not clear why negative selection has not removed this deletion from the population.
RESULTS: Here, we show that the haplotype block that harbors the deletion (i) retains high allele frequency among extant and ancient human populations; (ii) harbors unusually high nucleotide variation (π, P < 4.1 × 10-3); (iii) contains an excess of intermediate frequency variants (Tajima's D, P < 3.9 × 10-3); and (iv) has an unusually long time to coalescence to the most recent common ancestor (TSel, 0.1 quantile).
CONCLUSIONS: Our results are most parsimonious with the scenario where the LCE3BC deletion has evolved under balancing selection in humans. More broadly, this is consistent with the hypothesis that a balance between autoimmunity and natural vaccination through increased exposure to pathogens maintains this deletion in humans.

Entities:  

Keywords:  Atopic dermatitis; Copy number variation; Defensins; Genomic structural variants; HLA; Human evolution; LCE3A; Neanderthal

Mesh:

Substances:

Year:  2016        PMID: 27919236      PMCID: PMC5139038          DOI: 10.1186/s12862-016-0842-6

Source DB:  PubMed          Journal:  BMC Evol Biol        ISSN: 1471-2148            Impact factor:   3.260


Background

Genomic structural variants (SVs), which are deletions, duplications, inversions and translocations of genomic segments, account for the majority of variable base pairs in primate genomes [1, 2]. Because of their sheer size, SVs can have strong effects on gene function and regulation if they overlap with protein-coding (eg, [3]) or regulatory sequences (eg, [4]). Indeed, several studies have revealed important roles that SVs play in human evolution [2, 5] and adaptation [6, 7]. Disruption of a gene’s function by deletion of its coding sequence likely reduces fitness and predisposes humans to several genetic disorders (eg, [8-10]). Consistent with this notion, deletion variants among humans are distributed significantly away from coding sequences [11] and most exonic deletions are found in very low frequencies in human populations [12]. In a recent study, we searched for unusually old deletion variants that affect coding sequences. Specifically, we identified exonic deletions that evolved before Human-Neanderthal divergence (>500-1,000KYA) [13]. We surmised that it is unlikely for a loss-of-function gene deletion to be maintained for this long, especially under negative selection. Thus, we hypothesized that a number of these ancient deletion variants have been evolving under balancing selection. Balancing selection has enjoyed a renewed interest in the evolutionary genomics community. In its most basic form, balancing selection can be thought of as the combination of adaptive forces that maintain variation longer than expected under neutrality [14, 15]. Based on the analyses of recently available human and nonhuman primate genomes, several variants have been shown to be evolving under long-term balancing selection in the human-chimpanzee lineage [16, 17]. In addition, multiple instances of balancing selection within the human gene pool have been reported in the last decade [18-23]. In this paper, we investigate the evolution of an ancient gene deletion (LCE3BC deletion). This ~32kb deletion variant overlaps 2 genes, LCE3B and LCE3C, which are both involved in skin tissue repair. We recently showed that this deletion variant is derived in the Homo lineage and that the deletion is present in the Denisovan genome, but absent in the Neanderthal genome [13]. In the same study, we were able to rule out archaic introgression and concluded that incomplete lineage sorting best explains the observed allele sharing at this locus. The deletion is very common in humans, reaching up to 70% in some European populations. Moreover, this deletion has been strongly associated with psoriasis susceptibility, with odds ratios ranging from 1.3 (The Italian population) to 1.9 (The Chinese population) [24-27]. However, the adaptive reasons for why this deletion remains in the population are unknown.

Results

The LCE3BC deletion spans slightly more than 32kb in the human reference genome and overlaps with two conserved, protein coding genes, LCE3B and LCE3C (Fig. 1). We manually confirmed that this deletion has been shared with Denisovans, but not with Neanderthals (Additional file 1: Figure S1). We then determined single nucleotide variants that are in high linkage disequilibrium (R2 > 0.9) with the LCE3BC deletion among 2504 human genomes independent of population ancestry [28] (Additional file 2: Table S1). Using this dataset, we identified a haplotype block that comprises the LCE3BC deletion and its flanking sequences extending to 6.6kb downstream and 5.5kb upstream (Additional file 1: Figure S2).
Fig. 1

Genomic location of the LCE3BC deletion. Top: Location of the LCE3BC deletion on chromosome 1q21.3 (red circle). Below: The zoomed-in look at the region harboring the LCE3BC deletion. The red bar shows where the deletion occurs (Hg19, chr1:152,555,540–152,587,750). The blue bar represents the 5.6 kb “target” (chr1: 152,587,904–152,593,549) sequence that we used to conduct the majority of the population genetics analyses in this study

Genomic location of the LCE3BC deletion. Top: Location of the LCE3BC deletion on chromosome 1q21.3 (red circle). Below: The zoomed-in look at the region harboring the LCE3BC deletion. The red bar shows where the deletion occurs (Hg19, chr1:152,555,540–152,587,750). The blue bar represents the 5.6 kb “target” (chr1: 152,587,904–152,593,549) sequence that we used to conduct the majority of the population genetics analyses in this study We constructed a maximum likelihood tree of the variation in the region downstream of the LCE3BC deletion (target region) among 5008 modern human haplotypes, as well as Denisovan, Altai Neanderthal, Chimpanzee and Rhesus Macaque haplotypes (Fig. 2a, Additional file 1: Figure S3). We found a clear separation of two haplogroups (named hereon deleted and non-deleted) with perfect segregation of haplotypes carrying the deletion and those that do not. Furthermore, the Denisovan haplotype, which carries the deletion, clusters with the deleted human haplotypes, while the Neanderthal haplotype, which does not carry the deletion, clusters with the non-deleted haplotypes (Fig. 2a). This observation provides further support that the LCE3BC deletion evolved before Human-Denisovan split and remains variable since then.
Fig. 2

Global haplotype variation of the LCE3BC locus and allele frequency of the LCE3BC deletion in modern and ancient populations. a Simplified phylogenetic tree based on 5008 human haplotypes from the 1000 Genomes Project. We constructed the tree using the single nucleotide variants downstream of the deletion (also see Additional file 1: Figure S3). Haplotypes separated into two distinct haplogroups, which segregate into haplotypes that carry the deletion (deleted, red circle) and those that do not carry the deletion (non-deleted, blue circle). Frequency pie charts were superimposed to the tree for an overview of the distribution of the major haplotype groups across continental populations (Africans: [ACB, ASW, ESN, GWD, LWK, MSL, YRI], Asians: [BEB, CDX, CHB, CHS, GIH, ITU, JPT, KHV, PJL, STU] and Europeans: [CEU, FIN, GBR, IBS, TSI]). b Frequency distribution of the LCE3BC deletion in ancient human genomes. The x-axis indicates the date of the samples. The y-axis indicates the allele frequency of the deletion (as imputed by the frequency of tag single nucleotide variants rs6693105). The population acronyms are EN: Early Neolithic European; MN: Middle Neolithic European; BA: Bronze Age European. Each blue box indicates the ancient population and the length of the box spans the estimated age of the samples. The sample size of each population is indicated by the red number on the top or bottom of each box. c The geographic distribution of the LCE3BC deletion allele frequency. The red color indicates the frequency of the haplotypes in each population carrying the deletion, whereas white are haplotypes without the deletion

Global haplotype variation of the LCE3BC locus and allele frequency of the LCE3BC deletion in modern and ancient populations. a Simplified phylogenetic tree based on 5008 human haplotypes from the 1000 Genomes Project. We constructed the tree using the single nucleotide variants downstream of the deletion (also see Additional file 1: Figure S3). Haplotypes separated into two distinct haplogroups, which segregate into haplotypes that carry the deletion (deleted, red circle) and those that do not carry the deletion (non-deleted, blue circle). Frequency pie charts were superimposed to the tree for an overview of the distribution of the major haplotype groups across continental populations (Africans: [ACB, ASW, ESN, GWD, LWK, MSL, YRI], Asians: [BEB, CDX, CHB, CHS, GIH, ITU, JPT, KHV, PJL, STU] and Europeans: [CEU, FIN, GBR, IBS, TSI]). b Frequency distribution of the LCE3BC deletion in ancient human genomes. The x-axis indicates the date of the samples. The y-axis indicates the allele frequency of the deletion (as imputed by the frequency of tag single nucleotide variants rs6693105). The population acronyms are EN: Early Neolithic European; MN: Middle Neolithic European; BA: Bronze Age European. Each blue box indicates the ancient population and the length of the box spans the estimated age of the samples. The sample size of each population is indicated by the red number on the top or bottom of each box. c The geographic distribution of the LCE3BC deletion allele frequency. The red color indicates the frequency of the haplotypes in each population carrying the deletion, whereas white are haplotypes without the deletion We then traced back the allele frequency of rs6693105, which tags the LCE3BC deletion in all modern humans (R2 = 0.95), in recently available ancient genomes (Additional file 3: Table S2). We found that the genome of the 45,000 year old individual from Central Asia (Altai) [29] is heterozygous for the deletion allele (Fig. 2b). In fact, we were able to directly confirm the loss of read-depth due to heterozygous deletion in this sample (Additional file 1: Figure S1). We also found that the deletion haplotype has always been found in high frequency in ancient European populations (Fig. 2b). The LCE3BC deletion is very common in extant human populations as well, reaching major allele status in all non-African populations (Fig. 2c). To explain the evolutionary forces that shape this ancient (older than Human-Denisovan divergence) and very common allele (>50% frequency in most populations), we consider three scenarios. First, it is plausible that the LCE3BC deletion evolved under neutrality (eg, [30]). Indeed, in a recent study, we provided evidence that a neighboring gene, FLG, harbors neutrally evolving common loss-of-function variants [31]. In this scenario, we would expect the haplotype block carrying the deletion variant to show no significant deviation in tests of neutrality, when compared to neutral regions of the genome. Second, we considered positive selection, which would increase the frequency of this variant in human populations. Such cases were reported for other loss of function variants [32]. In this scenario, we expect increased population divergence (F ) [33] and deviation from expected homozygosity (delta integrated homozygosity score (∆iHH)) [34], but reduced nucleotide diversity (π). Third, we considered balancing selection, where we expect high π and a deviation from the expected frequency site spectrum (eg, positive values of Tajima’s D). To test the above hypotheses, we compared different population genetics statistics for the LCE3BC haplotype block to those calculated for neutrally evolving regions as defined by Arbiza et al. [35] (Additional file 4: Table S3). We found no significant increase of ∆iHH or FST in the LCE3BC haplotype block as compared to neutral regions (Additional file 1: Figure S4). In contrast, we observed that nucleotide diversity (π) in the LCE3BC haplotype block is at least 2 fold higher than neutral regions (Wilcoxon Test, CEU - P < 4.1 × 10−3; CHB - P < 7.7 × 10−4; YRI - P < 2.2 × 10−3) (Table 1, Fig. 3a) Similarly, Tajima’s D statistics in the LCE3BC haplotype block was significantly higher than neutral regions in all populations tested (Wilcoxon Test, CEU - P < 1.5 × 10−3; CHB - P < 1.5 × 10−3; YRI - P < 3.9 × 10−3) (Table 1, Fig. 3b). Tajima’s D compares the pairwise differences between haplotypes and the number of segregating sites [36]. In practice, positive values of Tajima’s D indicate an excess of intermediate frequency variants, which is a hallmark of balancing selection. Last but not least, we found that the region 10kb downstream of the LCE3BC deletion is within the 10th percentile of genome-wide distribution of pairwise time to most recent common ancestor as measured by Tsel method [37].
Table 1

Summarized mean and standard deviation values for Tajima’s D and Pi for different population and for the target and neutral regions, as well as regions adjacent to comparable nonexonic ancient deletions

PopulationRegionTajima’s DPi
CEUTarget2.65+/−0.1345.48 +/−5.62
Neutral0.41+/−0.8729.65 +/−12.56
Non-Exon0.49 +/−1.0531.32 +/−35.12
CHBTarget2.97+/−0.1348.00 +/−8.67
Neutral0.49 +/−0.9627.73 +/−12.53
Non-Exon0.46 +/−1.1929.21 +/−35.38
YRITarget0.66+/−0.1653.58 +/−8.14
Neutral−0.27+/−0.5439.30 +/−13.21
Non-Exon−0.17 +/−0.7040.29 +/−31.30
Fig. 3

Population genetics summary statistics (a) Y-axis of the boxplot shows the nucleotide diversity (π) and (b) Tajima’s D in three different populations (CEU: Central Europeans from Utah; CHB: Han Chinese from Beijing; and YRI: Yoruba from Ibadan Nigeria). The red boxes represent all regions of the genome that are predicted to be evolving under neutrality, whereas the blue boxes represent the data points from the LCE3BC haplotype block. The green boxes represent π and Tajima’s D scores calculated for the size-matched downstream regions of non-exonic ancient deletions. These deletions are comparable to the LCE3BC deletion in the sense that they were also found to have evolved before Human Neanderthal/Denisovan divergence and that they are similarly high in allele frequency [58]. P-values (Wilcoxon Test) are shown on top of the comparisons

Summarized mean and standard deviation values for Tajima’s D and Pi for different population and for the target and neutral regions, as well as regions adjacent to comparable nonexonic ancient deletions Population genetics summary statistics (a) Y-axis of the boxplot shows the nucleotide diversity (π) and (b) Tajima’s D in three different populations (CEU: Central Europeans from Utah; CHB: Han Chinese from Beijing; and YRI: Yoruba from Ibadan Nigeria). The red boxes represent all regions of the genome that are predicted to be evolving under neutrality, whereas the blue boxes represent the data points from the LCE3BC haplotype block. The green boxes represent π and Tajima’s D scores calculated for the size-matched downstream regions of non-exonic ancient deletions. These deletions are comparable to the LCE3BC deletion in the sense that they were also found to have evolved before Human Neanderthal/Denisovan divergence and that they are similarly high in allele frequency [58]. P-values (Wilcoxon Test) are shown on top of the comparisons These standard tests of neutrality can be affected by the mutation rate, as well demographic history [38]. One specific worry was whether preselecting a known “ancient” deletion that is shared with an archaic hominin species may bias our results. For example, it is possible that increased π may be due to the fact that the variation in this locus is older than many other parts of the genome. To address this, we compared Tajima’s D and π observed for the LCE3BC haplotype block with those calculated for size matched regions downstream of 340 other “ancient”, non-exonic deletions. These deletions were previously found to be shared with Neanderthals and/or Denisovans due to incomplete lineage sorting and also present in high allele frequency in contemporary human populations. As such, they are comparable to the LCE3BC deletion both for their age and allele frequency. This analysis confirmed our previous observations that π (Wilcoxon Test, CEU - P < 7.6 × 10−3; CHB - P < 1.7 × 10−3; YRI - P < 4.9 × 10−3) and Tajima’s D (Wilcoxon Test, CEU - P < 1.9 × 10−3; CHB - P < 2.0 × 10−3; YRI - P < 1.5 × 10−2) calculated for the LCE3BC haplotype block is significantly higher than those calculated for other ancient deletion haplotype blocks (Fig. 3a and b). We also considered the potential impact of repetitive sequences to variant calling quality. As such, we confirmed all our main results, omitting variants coinciding with repetitive sequences (Additional file 1: Figures S5–S7).

Discussion

In this study, we analyzed the haplotype block specifically because it harbors an ancient, exonic and disease-associated deletion variant. Our analyses of the haplotypic variation harboring this deletion best fits a model where the LCE3BC deletion has been maintained under balancing selection in human populations. What remains an open question is the adaptive pressure(s) on the LCE3B and LCE3C gene functions at the organismal and ecological levels. The phenotypic impact of the LCE3BC deletion has been discussed extensively, especially within the context of psoriasis biology (reviewed in [39]). Briefly, LCE3B and LCE3C coding sequences, which remain highly conserved across mammals (Additional file 1: Figure S8), are both active in skin barrier repair. As such, their expression is mostly confined to injured skin [40] and deletion of these genes likely leads to inefficient skin barrier repair. In addition, a likely regulatory region is also eliminated by the deletion [41] (Additional file 1: Figure S8). It also appears that the deletion haplotype leads to a significant increase in LCE3A expression in sun-exposed skin (Additional file 1: Figure S9), which may be a partial compensatory response to loss of LCE3B and LCE3C activity. It is unknown how the lack of LCE3B and LCE3C activity due to their deletion leads to psoriasis susceptibility. Variants that are related to skin structure (eg, LCE3BC deletion [24]) and variants related to immune function [42-44] are independently associated with psoriasis. Moreover, epistatic interactions between HLA-C*06 and LCE3BC loci were reported within the context of psoriasis [24, 25]. Briefly, it appears that the LCE3BC deletion leads to slower repair of the epidermal barrier, which in turn leads to increased exposure to environmental antigens and pathogens. The higher level of exposure consequently leads to higher activity of immune elements, and occasionally pathological autoimmune response. Based on the above-described mechanism, Bergboer et al. [39] hypothesized that the LCE3BC deletion would be favored to increase the effectiveness of the acquired immunity system (ie, natural vaccination), with the drawback of increasing the susceptibility to autoimmune disorders. In fact, it is plausible that the effect of the LCE3BC deletion on the immune system may be more than skin-deep, as the deletion was also associated with more systemic autoimmune disorders, such as psoriatic arthritis [45] and lupus [46]. Our findings presented here are concordant with this hypothesis.

Conclusion

The recent availability of high quality whole genome data at the population level provides novel opportunities to investigate complex evolutionary forces that shape disease susceptibility loci without ascertainment bias. Using such an approach, we provide multiple lines of evidence that a common, 32kb deletion strongly associated with psoriasis has evolved under balancing selection in the human lineage [47]. Our study presents empirical evidence that balancing selection on the LCE3BC deletion contributes to this very interesting dynamic. Our results will also contribute to the renewed discussion in the community on balancing selection maintaining advantageous diversity in human populations [17, 18, 22].

Methods

This 5.6kb region was selected based on the linkage disequilibrium between the single nucleotide variants and the deletion (R2 > 0.8) (Additional file 2: Table S1). Therefore, we surmised that this region is the haplotype block that harbors the deletion and we expect that the characteristics of the genetic variation within this region would inform us with regards to the evolutionary forces that shape the deletion as well. To investigate genetic variation within the LCE3BC haplotype block, we utilized the 1000 Genomes Project dataset, which includes 2504 human genomes across 26 populations [28], multiple ancient genomes [29, 48–50], chimpanzee and rhesus macaque reference haplotypes [51, 52] (Additional file 2: Table S1 and Additional file 3: Table S2). To do this, we used a custom pipeline, which is available at github (https://github.com/duoduoo/VCFtoTree). It has been shown that single nucleotide variation calling in next generation resequencing data may be affected in regions with duplicated or repeat-rich regions of the genome. We previously verified that all the single nucleotide variants that we used in our analyses have passed the 1000 Genomes quality filters (Quality score = 100) [11]. However, to further ensure that our analyses are not biased with repeated segments of the genome, we checked the target region where we conducted our analyses for presence of segmental duplications and other repetitive sequences. In addition, we used BLAT to check sequence uniqueness of this region. These analyses confirmed that there are no segmental duplications within our target region, but detected an L1 element (Fig. 1). Based on this search, we found an L1 element within the target region (Additional file 1: Figure S5, chr1:152,587,904–152,590,051). Since, it is plausible that this element can cause spurious single nucleotide variant calls, creating increased heterozygosity, we re-conducted our main analyses on the newly constructed target region (chr1:152,590,052–152,593,549), omitting the LINE element. The results confirm that our original conclusions remain unchanged, based on identical differentiation of haplogroups on the maximum likelihood tree (Additional file 1: Figure S6) and unchanged results for Tajima’s D and π (Additional file 1: Figure S7). We constructed a maximum likelihood tree using RAxML [53] with single nucleotide variants downstream of the deletion [Hg19-chr1: 152,587,904–152,593,549]. The alignments can be found as a supplementary file as well as on our website (gokcumenlab.org/data-and-codes/). We used Dendroscope [54] program for visualization. We constructed a rooted maximum likelihood tree using PhyML (HKY85 model) and we bootstrapped with 1000 replicates for branch support. We used values calculated by the 1000 Genomes Selection Browser [55] for comparing multiple population genetics parameters. To visually inspect the deletion variation in archaic humans, we used Integrated Genome Viewer [56]. We used ENCODE and Gtex databases to search for functional variants within the LCE3BC haplotype block. For compiling allele frequencies in ancient genomes, we used PLINK [57]. We used Python and R for custom bioinformatic and statistical analyses of the genetic variation. The R codes and processed datasets to replicate our core analyses are available as supplemental files (Additional File 5: File S1, Additional File 6: File S2) as well as on our website (http://gokcumenlab.org/data-and-codes/).
  56 in total

1.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Authors:  F Tajima
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

2.  Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6.

Authors:  Eva Riveira-Munoz; Su-Min He; Georgia Escaramís; Philip E Stuart; Ulrike Hüffmeier; Catherine Lee; Brian Kirby; Akira Oka; Emiliano Giardina; Wilson Liao; Judith Bergboer; Kati Kainu; Rafael de Cid; Batmunkh Munkhbat; Patrick L J M Zeeuwen; John A L Armour; Annie Poon; Tomotaka Mabuchi; Akira Ozawa; Agnieszka Zawirska; A David Burden; Jonathan N Barker; Francesca Capon; Heiko Traupe; Liang-Dan Sun; Yong Cui; Xian-Yong Yin; Gang Chen; Henry W Lim; Rajan P Nair; John J Voorhees; Trilokraj Tejasvi; Ramón Pujol; Namid Munkhtuvshin; Judith Fischer; Juha Kere; Joost Schalkwijk; Anne Bowcock; Pui-Yan Kwok; Giuseppe Novelli; Hidetoshi Inoko; Anthony W Ryan; Richard C Trembath; André Reis; Xue-Jun Zhang; James T Elder; Xavier Estivill
Journal:  J Invest Dermatol       Date:  2010-11-25       Impact factor: 8.551

Review 3.  Exploring the role of copy number variants in human adaptation.

Authors:  Rebecca C Iskow; Omer Gokcumen; Charles Lee
Journal:  Trends Genet       Date:  2012-04-05       Impact factor: 11.639

4.  Diet and the evolution of human amylase gene copy number variation.

Authors:  George H Perry; Nathaniel J Dominy; Katrina G Claw; Arthur S Lee; Heike Fiegler; Richard Redon; John Werner; Fernando A Villanea; Joanna L Mountain; Rajeev Misra; Nigel P Carter; Charles Lee; Anne C Stone
Journal:  Nat Genet       Date:  2007-09-09       Impact factor: 38.330

5.  Psoriasis is associated with increased beta-defensin genomic copy number.

Authors:  Edward J Hollox; Ulrike Huffmeier; Patrick L J M Zeeuwen; Raquel Palla; Jesús Lascorz; Diana Rodijk-Olthuis; Peter C M van de Kerkhof; Heiko Traupe; Gys de Jongh; Martin den Heijer; André Reis; John A L Armour; Joost Schalkwijk
Journal:  Nat Genet       Date:  2007-12-02       Impact factor: 38.330

6.  The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region.

Authors:  Luis B Barreiro; Etienne Patin; Olivier Neyrolles; Howard M Cann; Brigitte Gicquel; Lluís Quintana-Murci
Journal:  Am J Hum Genet       Date:  2005-09-29       Impact factor: 11.025

7.  The complete genome sequence of a Neanderthal from the Altai Mountains.

Authors:  Kay Prüfer; Fernando Racimo; Nick Patterson; Flora Jay; Sriram Sankararaman; Susanna Sawyer; Anja Heinze; Gabriel Renaud; Peter H Sudmant; Cesare de Filippo; Heng Li; Swapan Mallick; Michael Dannemann; Qiaomei Fu; Martin Kircher; Martin Kuhlwilm; Michael Lachmann; Matthias Meyer; Matthias Ongyerth; Michael Siebauer; Christoph Theunert; Arti Tandon; Priya Moorjani; Joseph Pickrell; James C Mullikin; Samuel H Vohr; Richard E Green; Ines Hellmann; Philip L F Johnson; Hélène Blanche; Howard Cann; Jacob O Kitzman; Jay Shendure; Evan E Eichler; Ed S Lein; Trygve E Bakken; Liubov V Golovanova; Vladimir B Doronichev; Michael V Shunkov; Anatoli P Derevianko; Bence Viola; Montgomery Slatkin; David Reich; Janet Kelso; Svante Pääbo
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

8.  Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.

Authors:  Hansjörg Baurecht; Melanie Hotze; Stephan Brand; Carsten Büning; Paul Cormican; Aiden Corvin; David Ellinghaus; Eva Ellinghaus; Jorge Esparza-Gordillo; Regina Fölster-Holst; Andre Franke; Christian Gieger; Norbert Hubner; Thomas Illig; Alan D Irvine; Michael Kabesch; Young A E Lee; Wolfgang Lieb; Ingo Marenholz; W H Irwin McLean; Derek W Morris; Ulrich Mrowietz; Rajan Nair; Markus M Nöthen; Natalija Novak; Grainne M O'Regan; Stefan Schreiber; Catherine Smith; Konstantin Strauch; Philip E Stuart; Richard Trembath; Lam C Tsoi; Michael Weichenthal; Jonathan Barker; James T Elder; Stephan Weidinger; Heather J Cordell; Sara J Brown
Journal:  Am J Hum Genet       Date:  2015-01-08       Impact factor: 11.025

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  17 in total

1.  DNA methylation-based subclassification of psoriasis in the Chinese Han population.

Authors:  Fusheng Zhou; Changbing Shen; Yi-Hsiang Hsu; Jing Gao; Jinfa Dou; Randy Ko; Xiaodong Zheng; Liangdan Sun; Yong Cui; Xuejun Zhang
Journal:  Front Med       Date:  2018-04-05       Impact factor: 4.592

Review 2.  Recent evolution of the human skin barrier.

Authors:  Erin A Brettmann; Cristina de Guzman Strong
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

3.  Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline.

Authors:  Audrey Bui; Jared Liu; Julie Hong; Edward Hadeler; Megan Mosca; Nicholas Brownstone; Wilson Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2021-06-21

Review 4.  An Evolutionary Perspective on the Impact of Genomic Copy Number Variation on Human Health.

Authors:  Marie Saitou; Omer Gokcumen
Journal:  J Mol Evol       Date:  2019-09-14       Impact factor: 2.395

5.  Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis.

Authors:  Amitis Karrys; Islam Rady; Roxane-Cherille N Chamcheu; Marya S Sabir; Sanchita Mallick; Jean Christopher Chamcheu; Peter W Jurutka; Mark R Haussler; G Kerr Whitfield
Journal:  Nutrients       Date:  2018-02-04       Impact factor: 5.717

6.  Archaic Hominin Introgression in Africa Contributes to Functional Salivary MUC7 Genetic Variation.

Authors:  Duo Xu; Pavlos Pavlidis; Recep Ozgur Taskent; Nikolaos Alachiotis; Colin Flanagan; Michael DeGiorgio; Ran Blekhman; Stefan Ruhl; Omer Gokcumen
Journal:  Mol Biol Evol       Date:  2017-10-01       Impact factor: 16.240

7.  VCFtoTree: a user-friendly tool to construct locus-specific alignments and phylogenies from thousands of anthropologically relevant genome sequences.

Authors:  Duo Xu; Yousef Jaber; Pavlos Pavlidis; Omer Gokcumen
Journal:  BMC Bioinformatics       Date:  2017-09-26       Impact factor: 3.169

8.  Complex Haplotypes of GSTM1 Gene Deletions Harbor Signatures of a Selective Sweep in East Asian Populations.

Authors:  M Saitou; Y Satta; O Gokcumen
Journal:  G3 (Bethesda)       Date:  2018-08-30       Impact factor: 3.154

9.  Expression Changes of Structural Protein Genes May Be Related to Adaptive Skin Characteristics Specific to Humans.

Authors:  Nami Arakawa; Daisuke Utsumi; Kenzo Takahashi; Akiko Matsumoto-Oda; Atunga Nyachieo; Daniel Chai; Ngalla Jillani; Hiroo Imai; Yoko Satta; Yohey Terai
Journal:  Genome Biol Evol       Date:  2019-03-01       Impact factor: 3.416

10.  Complex evolution of the GSTM gene family involves sharing of GSTM1 deletion polymorphism in humans and chimpanzees.

Authors:  M Saitou; Y Satta; O Gokcumen; T Ishida
Journal:  BMC Genomics       Date:  2018-04-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.